StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.64−0.00 (-0.28%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

DataMeds AI gross margin

Gross margin is gross profit as a percentage of revenue.

DataMeds AI's gross margin for the twelve months ending Sep 30, 2026 was -92.1%. For fiscal 2025 it was -27.5%, against 9.7% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-27.5%−37.3
FY2024Dec 31, 20249.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202616.2%+8.5
Q2 FY2026Jun 30, 202610.2%+3.7
Q1 FY2026Mar 31, 202610.9%+4.5
Q4 FY2025Dec 31, 2025-470.2%−480.3
Q3 FY2025Sep 30, 20257.7%−1.5
Q2 FY2025Jun 30, 20256.5%+12.3
Q1 FY2025Mar 31, 20256.4%–
Q4 FY2024Dec 31, 202410.1%–
Q3 FY2024Sep 30, 20249.2%–
Q2 FY2024Jun 30, 2024-5.9%–

More DataMeds AI figures

See a number that looks wrong?